secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001493152-23-008904
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce shareholders approve reverse stock split at ratio of 1:5 to 1:12
------------------------------------------------------------------------

- Reverse split proposal approved with 2,836,326,468 For, 280,656,829 Against, 19,762,315 Abstain.
- Board authorized to set exact ratio between 1-for-5 and 1-for-12 at its discretion.
- Second proposal lacked quorum and was not voted; adjournment proposal not submitted.
- Special meeting held March 23, 2023; only reverse split proposal was submitted to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/0001493152-23-008904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer